These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26952917)

  • 1. A Perspective on the State of Genome Editing.
    Carroll D
    Mol Ther; 2016 Mar; 24(3):412-3. PubMed ID: 26952917
    [No Abstract]   [Full Text] [Related]  

  • 2. A New Induction to the Gene and Cell Therapy Hall Of Fame: Genome Editing.
    Sadelain M
    Mol Ther; 2016 Mar; 24(3):407-8. PubMed ID: 26952914
    [No Abstract]   [Full Text] [Related]  

  • 3. Genome Editing Techniques and Their Therapeutic Applications.
    Calos MP
    Clin Pharmacol Ther; 2017 Jan; 101(1):42-51. PubMed ID: 27783398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Take Risks and Constantly Challenge the Status Quo.
    Cong L
    Stem Cells Dev; 2019 Jun; 28(11):709. PubMed ID: 31090491
    [No Abstract]   [Full Text] [Related]  

  • 5. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.
    Sanjurjo-Soriano C; Kalatzis V
    Neural Plast; 2018; 2018():5056279. PubMed ID: 29853845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Human Genome Editing Race: Loosening Regulatory Standards for Commercial Advantage?
    Cathomen T; Schüle S; Schüßler-Lenz M; Abou-El-Enein M
    Trends Biotechnol; 2019 Feb; 37(2):120-123. PubMed ID: 30017092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing for human osteoarthritis - a perspective.
    Almarza D; Cucchiarini M; Loughlin J
    Osteoarthritis Cartilage; 2017 Aug; 25(8):1195-1198. PubMed ID: 28529161
    [No Abstract]   [Full Text] [Related]  

  • 8. Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.
    Musunuru K
    J Am Coll Cardiol; 2017 Dec; 70(22):2808-2821. PubMed ID: 29191331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-viral delivery of genome-editing nucleases for gene therapy.
    Wang M; Glass ZA; Xu Q
    Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene editing in T cell therapy.
    Zhang Y; Mu W; Wang H
    J Genet Genomics; 2017 Sep; 44(9):415-422. PubMed ID: 28967616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome Editing of Structural Variations: Modeling and Gene Correction.
    Park CY; Sung JJ; Kim DW
    Trends Biotechnol; 2016 Jul; 34(7):548-561. PubMed ID: 27016031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preface for GCC Special Issue on noncoding RNAs, noncoding DNAs, and genome editing.
    Calin GA
    Genes Chromosomes Cancer; 2019 Apr; 58(4):189-190. PubMed ID: 30474323
    [No Abstract]   [Full Text] [Related]  

  • 13. ASGCT Meeting Showcases Fast-Paced Development of Gene and Cell Therapy Technologies.
    Herzog RW; Frederickson RM
    Mol Ther; 2020 Jul; 28(7):1547. PubMed ID: 32559431
    [No Abstract]   [Full Text] [Related]  

  • 14. Genome Editing in Retinal Diseases using CRISPR Technology.
    Yiu G
    Ophthalmol Retina; 2018 Jan; 2(1):1-3. PubMed ID: 31047294
    [No Abstract]   [Full Text] [Related]  

  • 15. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome editing for inborn errors of metabolism: advancing towards the clinic.
    Schneller JL; Lee CM; Bao G; Venditti CP
    BMC Med; 2017 Feb; 15(1):43. PubMed ID: 28238287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR genome-editing: A medical revolution.
    Butler JR; Tector AJ
    J Thorac Cardiovasc Surg; 2017 Feb; 153(2):488-491. PubMed ID: 28104200
    [No Abstract]   [Full Text] [Related]  

  • 18. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
    Salsman J; Masson JY; Orthwein A; Dellaire G
    Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic genome editing with engineered nucleases.
    Haas SA; Dettmer V; Cathomen T
    Hamostaseologie; 2017 Jan; 37(1):45-52. PubMed ID: 28070592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found.
    Carlson B
    Hum Gene Ther Clin Dev; 2016 Dec; 27(4):137-139. PubMed ID: 27983891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.